News

Keya medical's plaque analysis and FFR-CT reports generated from a single CT scan.

FDA clears AI-enabled CCTA plaque analysis tool from Keya Medical

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Cardiologists highlight early success with leaflet modification device for valve-in-valve TAVR

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

American College of Cardiology celebrates 100 hospitals for offering ‘highest level of cardiovascular care’

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?

Roderick Tung explains cardio-neuro ablation therapy for recurrent vasovagal syncope

Cardioneural ablation provides a new treatment option for vasovagal syncope

The procedure is designed to help patients who experience frequent fainting episodes that impair their quality of life.

Experts raise concern about high cost-sharing for imaging in some Medicare Advantage plans

"These high costs could pose barriers to care for such plans’ beneficiaries,” researchers wrote July 1 in the American Journal of Roentgenology.

cybersecurity cyberattack hack hackers lock protection

Homeland Security warns of vulnerabilities in medical imaging software

The feds cautioned that exploitation of these vulnerabilities could allow attackers to write files, access unauthorized information, or crash client servers.

University opens $30M new research imaging center focused on liver disease

The Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU seeks to develop new treatments that could help the millions of individuals impacted by these ailments.

PwC predicts: Providers, payers, pharma, medtech—all will have new to-do lists after the midterm elections. And that’s regardless of results.

With Election Day only four months away, healthcare is again emerging as a major source of idealistic campaign promises. Many of these are driven by widespread public angst. What sorts of changes can U.S. healthcare stakeholders realistically expect once the results are in?

PSMA PET imaging’s proliferation produces uptick in aggressive treatment for prostate cancer

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer.

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

CMS unveils $50 GLP-1 prescriptions for Medicare patients

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027. For $50 a month, Medicare beneficiaries will be able to access popular weight loss drugs, in hopes they will improve overall health.

Analysis: The public may not be wrong to think of the ED as the ‘front door’ of the hospital

The perception is probably more pronounced in community hospital EDs than their academic counterparts.

Medical malpractice gavel diagnostic error mistake stethoscope

Iowa hospital sued after allegedly extracting patient’s organs without family consent

In a lawsuit, the daughters of a deceased patient accuse Alegent Health-Community Memorial Hospital of Missouri Valley of medical malpractice and negligence, alleging donations were harvested without proper consultation. It’s alleged that their father was not registered as an organ donor.

Around the web

Cardiovascular Business

FDA clears AI-enabled CCTA plaque analysis tool from Keya Medical

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Cardiovascular Business

Cardiologists highlight early success with leaflet modification device for valve-in-valve TAVR

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

Cardiovascular Business

American College of Cardiology celebrates 100 hospitals for offering ‘highest level of cardiovascular care’

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?